pharma · Prophylaxis for the Measles Infection
Serum Life Science
Serum Life Science Europe GmbH
Serum Life Science is a pharma organization headquartered in EU. Primary therapeutic focus areas include Prophylaxis for the Measles Infection. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent
Hannover, DE HQ
2002 Founded
26 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Hannover, DE
- Founded
- 2002
- Employees
- 26
- Programs
- 1
- Drugs
- 0
- Patents
- 0
PMV via Puffhaler® device
Phase 1 · mab · Prophylaxis for the Measles Infection
PMV via Puffhaler® device for Prophylaxis for the Measles Infection is a Phase 1 program (mab) at Serum Life Science Europe GmbH with 1 ClinicalTrials.gov record(s).
Internal code PMV-001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Serum Life Science Europe GmbH
- Phase
- Phase 1
- Modality
- mab
- Indication
- Prophylaxis for the Measles Infection
- Status
- completed
- Trials
- 1